08.29.18 to 08.31.18
Minsk, Belarus

Amy Finan, chief executive officer of the Sabin Vaccine Institute, discussed Sabin’s commitment to vaccine development and the challenges of developing and bringing vaccines to market.

Why is Sabin committed to vaccine development?

In 2014, the Sabin Vaccine Institute began working with Georgia’s national government and partners to promote sustainable immunization financing and domestic resource mobilization for immunization. In more recent years, the focus has shifted to improving government immunization policy.

Typhoid is a common illness across much of Southeast Asia, where the bacterial disease spreads through contaminated food and water.

For 25 years, Sabin has been a trusted partner, working with countries, the World Health Organization (WHO), Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, and regional stakeholders to improve immunization.

When the Sabin Vaccine Institute’s Coalition against Typhoid held our most recent global conference in 2017, we could hardly have foreseen that it would be the

On April 23, 2018, 43 parliamentarians, joined by government officials and partners, gathered in Kinshasa, Democratic Republic of Congo, for a briefing on sustainable immunization financing.

During the last week in June, more than 200 members of the global immunization community, including stakeholders, partners and regional and country representatives, gathered in Kigali, Rwanda, for the 2018 Global Immunization Meeting.

The success of immunization programs relies heavily on immunization program managers, who facilitate every aspect of immunization programs, from cost-effective procurement of vaccines to the vigilant monitoring of vaccine safety and efficacy.

Pages